drugset / Trial / NCT00380835
Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the incidence of cardiac toxicity of amrubicin when administered to patients with metastatic breast cancer.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2007-12
Outcome
Outcome not reported
Stopped: “Study Never Initiated”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amrubicin | Small molecule | — | — |